Falgueyret J P, Leblanc Y, Riendeau D
Merck Frosst Centre for Therapeutic Research, Pointe Claire-Dorval, Québec, Canada.
FEBS Lett. 1990 Mar 26;262(2):197-200. doi: 10.1016/0014-5793(90)80188-o.
Cell-free preparations from rat polymorphonuclear leukocytes and skin were found to catalyze the reduction of 12-keto-5,8,10,14-eicosatetraenoic acid (12-KETE) to 12-hydroxyeicosatetraenoic acid (12-HETE). The reductase activity was associated with the microsomal fraction and showed a marked preference for NADH over NADPH as reducing cofactor. Characterization of the reaction product by chiral phase HPLC of the methyl ester derivative indicated that 12-KETE reduction generated almost exclusively 12(S)-HETE. The results demonstrate that rat skin and leukocyte microsomes possess an NADH-dependent 12-KETE reductase activity that forms 12(S)-HETE as a major product. The identification of stereoselective 12-KETE reductases provides a basis for further defining the role these enzymes may play in the regulation of 12-KETE levels and in the protection against degradation of 12-KETE to the pro-inflammatory 12(R)-HETE by selectively generating 12-HETE of the S configuration.
研究发现,来自大鼠多形核白细胞和皮肤的无细胞制剂能够催化12-酮基-5,8,10,14-二十碳四烯酸(12-KETE)还原为12-羟基二十碳四烯酸(12-HETE)。还原酶活性与微粒体部分相关,并且在作为还原辅因子方面,对NADH的偏好明显高于NADPH。通过甲酯衍生物的手性相HPLC对反应产物进行表征表明,12-KETE的还原几乎只生成12(S)-HETE。结果表明,大鼠皮肤和白细胞微粒体具有依赖NADH的12-KETE还原酶活性,该活性以12(S)-HETE作为主要产物。立体选择性12-KETE还原酶的鉴定为进一步确定这些酶在调节12-KETE水平以及通过选择性生成S构型的12-HETE来防止12-KETE降解为促炎的12(R)-HETE中可能发挥的作用提供了基础。